Spinal Implants & Devices Market Size, Share & Trends Analysis Report By Product, By Technology, By Surgery Type, By Procedure Type- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global spinal implants & devices market size was exhibited at USD 12.9 billion in 2022 and is projected to hit around USD 21.62 billion by 2032, growing at a CAGR of 5.3% during the forecast period 2023 to 2032.

Key Pointers:

• The Spinal Fusion Devices segment dominated the market with share of 58.9% in 2022
• The Vertebral compression fracture treatment devices segment is anticipated to grow at the fastest rate of 6.7% during the forecast period .
• Spinal Fusion and Fixation Technologies segment dominated the market with share of 68.8% in 2022
• Motion Preservation Technologies segment is anticipated to grow at the fastest rate of 8.4% during the forecast period .
• The spinal implants & devices market is segmented by surgery type into open surgery and MIS. Although gradually declining, however, open spine surgery is still widely performed.
• Laminotomy segment dominated the market with share of 38.9% in 2022 because it is the most common type of spine procedure performed. 
• The Foraminotomy segment is anticipated to grow at a fastest rate of 5.9% over the forecast period. 
• The North America segment dominated the market with share of 48.9% in 2022 
• The Asia Pacific segment is anticipated to grow at a fastest rate of 7.5% during the forecast period.

Spinal Implants & Devices Market Report Scope

The market growth can be attributed to the growing incidences of spinal cord injuries (SCIs) across the globe. Compression of the spinal cord or injury causes damage from the outside of the cord. This compression is mainly due to either spinal degeneration, bone fracture, or abnormalities, such as a hematoma or herniated disk.

The growing number of vehicular accidents is leading to increasing new cases of spinal cord injuries (SCIs). Other causes of SCIs include falls, violence, acts of violence, sports and recreation injuries, and diseases. Vehicular or road accidents and falls account for the majority of SCI cases.

Fall-induced SCI is common among people aged 65 years and above. Acts of violence such as gunshot wounds or knife wounds account for around 12% of SCI cases. Sports activities such as diving in shallow water and impact sports lead to nearly 10% of SCIs. Cancer, osteoporosis, arthritis, and inflammation of the spinal cord also cause SCI.

Based on National Spinal Cord Injury Statistical Center data, around 296,000 U.S. population are currently living with SCI. SCI cases are rising; according to WHO, about 90 % of SCI cases are traumatic, however, the number of non-traumatic SCI cases is rising. Further, it stated that around 20-30% of SCI patients showed clinically significant signs of depression. This adversely affects patients’ improvements in functioning and overall health. The consequences associated with SCI arise mainly due to inadequate access to medical care and rehabilitation services. Approximately 5-15 % of the population in middle- and low-income countries have access to the assisted devices needed to post spinal surgery.

Technological innovations in the field of spine surgery is also driving the market growth. Aprevo, by Carlsmed, is the first digital-to-device patient-specific interbody technology to treat adult spinal deformity (ASD). This system uses patient imaging data to create patient and surgeon-specific plans and develops personalized 3D printed spinal implants to achieve each plan. The titanium aprevo implants are personalized by shape, size, height, and coronal and lordotic angles. Since these implants provide more effective ASD treatment than a standard of care, so, in 2021, the U.S. FDA awarded aprevo Breakthrough Technology status.

Some of the prominent players in the Spinal implants & devices Market include:

• Medtronic
• Johnson & Johnson
• Stryker
• NuVasive
• Zimmer Biomet
• Globus Medical, Inc.
• Alphatec Spine, Inc.
• Orthofix Holdings, Inc.
• RTI Surgical Holdings
• Ulrich GmbH & Co. KG
• B. Braun Melsungen AG
• Seaspine Holdings Corporation

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global spinal implants & devices market.

By Product 

• Spinal Fusion Devices
  • Thoracic & Lumbar Fusion Devices
  • Cervical Fusion Devices
• Spinal Biologics
  • Allografts
  • Xenografts
  • DBM
  • BMP
  • Synthetic Bone Grafts
• Vertebral Compression Fracture Treatment Devices
• Non-fusion Devices
• Spinal Bone Growth Stimulators

By Technology 

• Spinal Fusion And Fixation Technologies
• Vertebral Compression Fracture Treatment
  • Vertebroplasty
  • Kyphoplasty/Vertebral Augmentation
• Motion Preservation Technologies

By Surgery Type

• Open Surgery
• Minimally Invasive Surgery

By Procedure Type 

• Discectomy
• Laminotomy
• Foraminotomy
• Corpectomy
• Facetectomy

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)